CustomPax Holdings Ltd Revenue and Competitors

Location

N/A

Total Funding

Health

Industry

Estimated Revenue & Valuation

  • CustomPax Holdings Ltd's estimated annual revenue is currently $61.8M per year.(i)
  • CustomPax Holdings Ltd's estimated revenue per employee is $297,000

Employee Data

  • CustomPax Holdings Ltd has 208 Employees.(i)
  • CustomPax Holdings Ltd grew their employee count by -2% last year.

CustomPax Holdings Ltd's People

NameTitleEmail/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$14.3M599%N/AN/A
#2
$179.6M5327%N/AN/A
#3
$6.5M303%N/AN/A
#4
$5.3M28-3%N/AN/A
#5
$12.4M5128%N/AN/A
#6
$13.6M56-10%N/AN/A
#7
$6.5M30-12%N/AN/A
#8
$18M746%N/AN/A
#9
$10.2M472%N/AN/A
#10
$181.6M53813%N/AN/A
Add Company

What Is CustomPax Holdings Ltd?

In the past two decades, music has gone from vinyl to iTunes; the Internet has transformed just about every industry; yet mainstream retailers are still selling bottles of dietary nutritional supplements like Vitamin C, D & A as before without differentiation. With its disruptive technology platform, CustomPax has redefined how vitamins are made, delivered and consumed, revolutionizing and transforming the US$100 billion a year global supplement market. CustomPax operates an ecommerce platform, powered by patent-pending software and drug-supplement interaction algorithmic engines and smart manufacturing, where doctors and consumers are empowered and involved in the co-production process, creating differentiated supplement formulations and thus a sustainable competitive advantage. Others manufacture first and then sell; we sell and then manufacture, we have a differentiated business model delivering customized products at mass production cost and efficiency, revolutionizing the world of vitamins and supplements. Our vision is better vitamins, better health. For doctors, oncologists and pharmacists, we integrate vitamin management into their EMR system; For consumers, we provide better vitamins by checking for and preventing supplement overdose and drug-supplement contraindications.

keywords:N/A

N/A

Total Funding

208

Number of Employees

$61.8M

Revenue (est)

-2%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$33.3M20928%N/A
#2
$67.4M2103%$1.5M
#3
$50.1M2176%N/A
#4
$68.4M226-20%N/A
#5
$34.6M230-8%$42.6M